Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy

Clinics - Tập 67 - Trang 1047-1052 - 2012
Antonio Marcelo Barbante Casella1, Rodrigo Fabri Berbel1, Gláucio Luciano Bressanim2, Marcus Rudolph Malaguido1, José Augusto Cardillo3
1Universidade Estadual de Londrina, Department of Ophthalmology, Londrina, Brazil.
2Instituto da Visão de Cascavel, Department of Ophthalmology, Cascavel, Brazil.
3Hospital de Olhos de Araraquara, Department of Ophthalmology, Araraquara, Brazil.

Tài liệu tham khảo

Tittl, 1999, Systemic and ocular findings in central serous chorioretinopathy, Am J Ophthalmol, 128, 8, 10.1016/S0002-9394(99)00075-6 Haimovici, 2004, Risk factors for central serous chorioretinopathy: a case-control study, Ophthalmology, 111, 9 Guyer, 1994, Central Serous Chorioretinopathy, 818 Spaide, 1996, Central serous chorioretinopathy in younger and older adults, Ophthalmology, 103, 80, 10.1016/S0161-6420(96)30386-2 Yannuzzi, 2003, Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot Study, Retina, 23, 98, 10.1097/00006982-200306000-00002 Carvalho-Recchia, 2002, Corticosteroids and central serous chorioretinopathy, Ophthalmology, 109, 7 Koyama, 2004, Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy, Ophthalmologica, 218, 10, 10.1159/000076145 Michael, 2003, Central serous chorioretinopathy associated with administration of sympathomimetic agents, Am J Ophthalmol, 136, 5, 10.1016/S0002-9394(03)00076-X Giusti, 2001, Central serous chorioretinopathy: a new extragastric manifestation of Helicobacter pylori? Analysis of a clinical case, Clin Ter, 152, 7 Mauget-Faÿsse, 2002, Rôle de l'Helicobacter pylori dans la choriorétinopathie séreuse centrale et l'épithéliopathie rétinienne diffuse. Résultats de la première étude prospective pilote, J Fr Ophtalmol, 25, 5 Ahnoux-Zabsonre, 2004, Prévalence de l'Helicobacter pylori dans la choriorétinopathie séreuse centrale et l'épithéliopathie rétinienne diffuse, J Fr Ophtalmol, 27, 33, 10.1016/S0181-5512(04)96281-X Asensio-Sánchez, 2008, Coriorretinopatía serosa central como manifestación extradigestiva de infección gástrica por Helicobacter pylori, Arch Soc Esp Oftalmol, 83, 82, 10.4321/S0365-66912008000300009 Giusti, 2004, Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis, Med Hypotheses, 63, 7, 10.1016/j.mehy.2004.02.020 Cotticelli, 2006, Central serous chorioretinopathy and Helicobacter pylori, European journal of ophthalmology, 16, 8, 10.1177/112067210601600213 Misiuk-Hojło, 2009, Helicobacter pylori–a risk factor for the development of the central serous chorioretinopathy, Klin Oczna, 111(1-3), 2 Rahbani-Nobar, 2011, The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy, Mol Vis, 17, 103 Ogata, 2001, Evolution of invasive and non-invasive methods for the diagnosis of Helicobacter pylori in symptomatic children and adolescents, São Paulo Med J, 119, 71, 10.1590/S1516-31802001000200006 Santos, 2005, Prevalence of Helicobacter pylori infection and associated factors among adults in Southern Brazil: a population-based cross-sectional study, BMC Public Health, 5, 118, 10.1186/1471-2458-5-118 Zaterka, 2007, Factors related to Helicobacter pylori prevalence in an adult population in Brazil, Helicobacter, 12, 8, 10.1111/j.1523-5378.2007.00474.x Mitchell, 1999, The epidemiology of Helicobacter pylori, Curr Top Microbiol Immunol, 241, 30 D'Elios, 2007, Helicobacter pylori: Inflammation, Immunity, and Vaccines, Helicobacter, 12, 15, 10.1111/j.1523-5378.2007.00530.x Maeda, 2007, Pathogenesis of Helicobacter pylori Infection, Helicobacter, 12 (Suppl.1), 4 Bohr, 2007, Extragastric Manifestations of Helicobacter pylori Infection – Other Helicobacters, Helicobacter, 12(Suppl. 1), 53 Whittle, 2001, Helicobacter pylori lipopolysaccharide provokes iNOS-mediated acute systemic microvascular inflammatory responses in rat cardiac, hepatic, renal and pulmonary tissues, J Physiol Paris, 95(1-6), 9 Giusti, 2004, Helicobacter pylori and idiopathic central serous chorioretinopathy, Swiss Med Wkly, 134(27-28), 8 Ushiama, 2002, Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol, Clin Pharmacol Ther, 72, 43, 10.1067/mcp.2002.125559 Mansuetta, 2004, An association between central serous chorioretinopathy and gastroesophageal reflux disease, Am J Ophthalmol, 137, 100, 10.1016/j.ajo.2004.01.054 Aggio, 2010, Clinical factors reralted to the visual outcome in central serous choriorretinopathy, Retina, 30, 34, 10.1097/IAE.0b013e3181cdf381 Abreu, 2008, Helicobacter pylori and central serous chorioretinopathy, Arch Soc Esp Oftalmol, 83, 8, 10.4321/S0365-66912008001100003